Danone S.A.
BN.PA · Euronext Paris · EUR
68,32EUR
+0,66 (+0,98 %)Stand 10. Nov., 16:35
Kennzahlen
- Eröffnung
- 67,98
- Vortag
- 67,66
- Tagesspanne
- 67,98 – 69,12
- 52 Wochen
- 57,26 – 80,14
- Volumen
- 1,55 Mio.
- Ø Volumen
- 1,33 Mio.
- Börsenwert
- 43,87 Mrd. €
- KGV
- 22,4
- Gewinn je Aktie (TTM)
- 5,89
- Dividendenrendite
- 3,3 %
- Beta
- 0,2
- Nächste Zahlen
- –
Finanzen
| EUR | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Umsatz | 27,28 Mrd. | 27,38 Mrd. | 27,62 Mrd. | 27,66 Mrd. | 24,28 Mrd. |
| Herstellungskosten | 13,47 Mrd. | 13,77 Mrd. | 14,54 Mrd. | 14,92 Mrd. | 12,76 Mrd. |
| Bruttogewinn | 13,81 Mrd. | 13,61 Mrd. | 13,08 Mrd. | 12,74 Mrd. | 11,52 Mrd. |
| Forschung und Entwicklung | 479 Mio. | 447 Mio. | 398 Mio. | 339 Mio. | 338 Mio. |
| Vertrieb und Verwaltung | 9,56 Mrd. | 9,5 Mrd. | 9,04 Mrd. | 8,93 Mrd. | 7,84 Mrd. |
| Operatives Ergebnis | 2,94 Mrd. | 3,38 Mrd. | 2,04 Mrd. | 2,14 Mrd. | 2,26 Mrd. |
| EBITDA | 4,39 Mrd. | 4,68 Mrd. | 5,1 Mrd. | 5,25 Mrd. | 4,6 Mrd. |
| Nettogewinn | 1,82 Mrd. | 2,02 Mrd. | 881 Mio. | 959 Mio. | 1,92 Mrd. |
| Gewinn je Aktie (verwässert) | 2,82 | 3,13 | 1,36 | 1,48 | 2,94 |
Bewertung
Letzte 12 Monate
- KGV
- 22,4
- Kurs-Umsatz-Verhältnis
- 1,6
- Kurs-Buchwert-Verhältnis
- 2,5
- PEG
- 3,2
- Bruttomarge
- 43,9 %
- Operative Marge
- 11,7 %
- Nettomarge
- 7,1 %
- Verschuldungsgrad
- 1,0
- EV/EBITDA
- 13,5
- Eigenkapitalrendite
- 11,3 %
- Kapitalrendite (ROIC)
- 6,0 %
- Free-Cashflow-Rendite
- 5,5 %
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Bruttomarge | 50,6 % | 49,7 % | 47,4 % | 46,1 % | 47,4 % |
| Operative Marge | 10,8 % | 12,3 % | 7,4 % | 7,7 % | 9,3 % |
| Nettomarge | 6,7 % | 7,4 % | 3,2 % | 3,5 % | 7,9 % |
| KGV | 27,1 | 20,7 | 43,1 | 33,3 | 18,6 |
| Kurs-Umsatz-Verhältnis | 1,8 | 1,5 | 1,4 | 1,1 | 1,5 |
| Kurs-Buchwert-Verhältnis | 2,9 | 2,4 | 2,3 | 1,8 | 2,0 |
| Verschuldungsgrad | 0,9 | 0,8 | 1,0 | 0,8 | 0,9 |
| Liquidität 3. Grades | 0,9 | 0,9 | 0,9 | 1,0 | 1,1 |
| Dividendenrendite | 2,8 % | 3,2 % | 3,4 % | 3,9 % | 3,6 % |
| Unternehmenswert | 62,52 Mrd. | 54,61 Mrd. | 50,85 Mrd. | 44,57 Mrd. | 50,82 Mrd. |
| EV/EBITDA | 14,2 | 11,7 | 10,0 | 8,5 | 11,0 |
| Eigenkapitalrendite | 10,8 % | 11,4 % | 5,4 % | 5,4 % | 11,1 % |
| Kapitalrendite (ROIC) | 5,9 % | 6,5 % | 3,2 % | 3,3 % | 4,6 % |
| Free-Cashflow-Rendite | 5,5 % | 6,9 % | 6,9 % | 6,6 % | 6,9 % |
Wachstum
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Umsatz | −0,3 % | −0,9 % | −0,2 % | +13,9 % | +2,8 % |
| Bruttogewinn | +1,5 % | +4,0 % | +2,7 % | +10,6 % | +1,5 % |
| Operatives Ergebnis | −13,0 % | +65,5 % | −4,7 % | −5,1 % | −19,3 % |
| Nettogewinn | −9,7 % | +129,4 % | −8,1 % | −50,2 % | −1,6 % |
| Gewinn je Aktie | −9,9 % | +130,1 % | −8,1 % | −49,7 % | −1,7 % |
| Freier Cashflow | −6,3 % | +12,1 % | +24,1 % | −14,0 % | +21,2 % |
| Dividende je Aktie | +2,3 % | +5,0 % | +3,0 % | −0,7 % | −7,0 % |
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Schätzungen
| FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|
| Umsatz (Ø) | 28,21 Mrd. | 29,63 Mrd. | 30,73 Mrd. |
| Umsatz (Tief – Hoch) | 27,44 Mrd. – 28,39 Mrd. | 28,69 Mrd. – 30,32 Mrd. | 29,72 Mrd. – 31,8 Mrd. |
| Gewinn je Aktie (Ø) | 3,96 | 4,23 | 4,52 |
| Gewinn je Aktie (Tief – Hoch) | 3,79 – 4,04 | 4,01 – 4,42 | 4,12 – 4,83 |
| Analysten | 16 | 16 | 12 |
Quartalszahlen
| Juli 2026 | Feb. 2026 | Juli 2025 | Feb. 2025 | Dez. 2024 | Juli 2024 | Feb. 2024 | Juli 2023 | |
|---|---|---|---|---|---|---|---|---|
| Gewinn je Aktie · Erwartet | 1,86 | 1,84 | 1,85 | 1,76 | 1,71 | 1,67 | 1,69 | 1,70 |
| Gewinn je Aktie · Tatsächlich | 1,83 | 1,88 | 1,64 | 1,82 | 1,80 | 1,77 | 1,83 | 1,80 |
| Abweichung | −1,61 % | +2,17 % | −11,35 % | +3,41 % | +5,26 % | +5,99 % | +8,28 % | +5,88 % |
| Umsatz · Tatsächlich | 13,79 Mrd. | 13,57 Mrd. | 13,74 Mrd. | 13,62 Mrd. | 13,76 Mrd. | 13,49 Mrd. | 14,17 Mrd. | 14,34 Mrd. |
Dividenden und Splits
| Ex-Tag | Zahltag | Betrag |
|---|---|---|
| 4. Mai 2026 | 6. Mai 2026 | 2,25 |
| 5. Mai 2025 | 7. Mai 2025 | 2,15 |
| 3. Mai 2024 | 7. Mai 2024 | 2,10 |
| 9. Mai 2023 | 11. Mai 2023 | 2,00 |
| 10. Mai 2022 | 12. Mai 2022 | 1,94 |
| 10. Mai 2021 | 12. Mai 2021 | 1,94 |
| 14. Juli 2020 | 16. Juli 2020 | 2,10 |
| 7. Mai 2019 | 9. Mai 2019 | 1,94 |
| 4. Mai 2018 | 31. Mai 2018 | 1,90 |
| 5. Mai 2017 | 1. Juni 2017 | 1,70 |
| 5. Mai 2016 | 9. Mai 2016 | 1,60 |
| 7. Mai 2015 | 3. Juni 2015 | 1,50 |
Aktiensplits
- 1. Juni 20091059:1000
- 1. Juni 20072:1
- 15. Juni 20042:1
- 5. Juni 20002:1
- 10. Aug. 199211:10
- 9. Jan. 198910:1
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
Über das Unternehmen
Danone S.A. is a major company within the food and beverage industry, conducting its operations across various global regions including Europe, North America (Noram), Latin America, Asia Pacific, Africa, and the Middle East. The company's business is organized into three principal segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. Under its Essential Dairy & Plant-Based division, Danone manufactures and distributes a broad array of products. This range includes yogurts, diverse milk products, coffee creamers, a variety of drinks and beverages, plant-based alternatives, ice creams, desserts, and powdered nutritional protein items. These are sold under proprietary brands such as Actimel, Activia, Alpro, Danette, Danio, and Danonino, as well as licensed brands including International Delight, Dunkin' Donuts, and Bailey's. The Specialized Nutrition segment focuses on providing tailored nutritional offerings. This encompasses products developed for pregnant and breastfeeding mothers, infants, and young children, marketed under names like Aptamil, Nutrilon, Gallia, Cow & Gate, Blédina, Bebelac, Olvarit, and Happy Family Organics. Additionally, this segment extends to medical nutrition, featuring tube feeding formulas (e.g., Nutrison), oral nutritional supplements (e.g., Fortimel, NutriDrink), and specialized hypoallergenic products for children with allergies (e.g., Aptamil ProSyneo, Aptamil Pepti Syneo, and Neocate Syneo). Within the Waters segment, Danone offers a portfolio of bottled water products, some of which are enhanced with natural fruit extracts, fruit juice, and vitamins. Key brands in this category include evian, Volvic, Aqua, Mizone, Bonafont, Villavicencio, Villa del Sur, Hayat, Sirma, Fontvella, Lanjarón, Salus, Aqua d'Or, and Zywiec Zdroj. Danone distributes its wide selection of products through multiple channels. These include large retail chains, traditional market outlets, convenience stores, healthcare settings such like hospitals, clinics, and pharmacies, and increasingly, through e-commerce platforms. Incorporated in 1899, the company was initially known as Groupe Danone before officially changing its name to Danone S.A. in April 2009. Its corporate headquarters are situated in Paris, France.
Führung
- Antoine Bernard de Saint-AffriqueChief Executive Officer & Non-Independent Director
- Veronique Penchienati-BosettaGroup Deputy Chief Executive Officer
- Henri BruxellesPresident of Americas
- Jean-Marc MagnaudetPresident of Specialized Nutrition
- Juergen EsserChief Financial, Technology & Data Officer and Group Deputy Chief Executive Officer
- Pablo E. PerversiPresident of Europe, Turkey, Middle East & Africa
- CEO
- Antoine Bernard de Saint-Affrique
- Mitarbeitende
- 88.670
- Hauptsitz
- Paris, IF, FR
- Sektor
- Consumer Defensive
- Branche
- Packaged Foods
- Börsengang
- 16. Jan. 1989
- Website
- danone.com
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.